Publications: DR Mine Koprulu
Pietzner M, Beuchel C, Demircan K, Hoffmann Anton J, Zeng W, Römisch-Margl W, Yasmeen S, Uluvar B et al.
(
2025
)
.
Machine learning-guided deconvolution of plasma protein levels
.
Molecular Systems Biology1
-
23
.
Zoodsma M, Beuchel C, Yasmeen S, Kohleick L, Nepal A, Koprulu M, Kronenberg F, Mayr M et al.
(
2025
)
.
A genetic map of human metabolism across the allele frequency spectrum
.
Nature Genetics
vol.
57
,
(
10
)
2445
-
2455
.
Koprulu M, Wheeler E, Kerrison ND, Denaxas S, Carrasco-Zanini J, Orkin CM, Hemingway H, Wareham NJ et al.
(
2025
)
.
Sex differences in the genetic regulation of the human plasma proteome
.
Nature Communications
vol.
16
,
(
1
)
Carrasco-Zanini J, Wheeler E, Uluvar B, Kerrison N, Koprulu M, Wareham NJ, Pietzner M, Langenberg C
(
2024
)
.
Mapping biological influences on the human plasma proteome beyond the genome
.
Nature Metabolism
vol.
6
,
(
10
)
2010
-
2023
.
Carrasco-Zanini J, Pietzner M, Koprulu M, Wheeler E, Kerrison ND, Wareham NJ, Langenberg C
(
2024
)
.
Proteomic prediction of diverse incident diseases: a machine learning-guided biomarker discovery study using data from a prospective cohort study
.
The Lancet Digital Health
vol.
6
,
(
7
)
e470
-
e479
.
Desai TA, Hedman ÅK, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL et al.
(
2024
)
.
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
.
EBioMedicine
vol.
105
,
Smith-Byrne K, Hedman Å, Dimitriou M, Desai T, Sokolov AV, Schioth HB, Koprulu M, Pietzner M et al.
(
2024
)
.
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers
.
Nature Communications
vol.
15
,
(
1
)
Iglesias MJ, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, Farm M, Smith PM et al.
(
2023
)
.
Author Correction: Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism
.
Nature Communications
vol.
14
,
(
1
)
Iglesias MJ, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, Farm M, Smith PM et al.
(
2023
)
.
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism
.
Nature Communications
vol.
14
,
(
1
)
Koprulu M, Carrasco-Zanini J, Wheeler E, Lockhart S, Kerrison ND, Wareham NJ, Pietzner M, Langenberg C
(
2023
)
.
Author Correction: Proteogenomic links to human metabolic diseases
.
Nature Metabolism
vol.
5
,
(
4
)
710
-
710
.
Koprulu M, Carrasco-Zanini J, Wheeler E, Lockhart S, Kerrison ND, Wareham NJ, Pietzner M, Langenberg C
(
2023
)
.
Proteogenomic links to human metabolic diseases
.
Nature Metabolism
vol.
5
,
(
3
)
516
-
528
.
Zanetti D, Koprulu M, Grosso F, Zhernakova DV, Crobu F, Sanna S
.
Exploring sex-specific causal links between thousands of proteins and lipid metabolism using the UK Biobank Pharma proteomics data
.
Desai TA, Hedman ÅK, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL et al.
.
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics
.
Smith-Byrne K, Hedman Å, Dimitriou M, Desai T, Sokolov AV, Schioth HB, Koprulu M, Pietzner M et al.
.
Identifying therapeutic targets for cancer: 2,094 circulating proteins and risk of nine cancers
.
Pietzner M, Beuchel C, Demircan K, Anton JH, Zeng W, Römisch-Margl W, Yasmeen S, Uluvar B et al.
.
Machine learning-guided deconvolution of plasma protein levels
.
Pietzner M, Williamson A, Hunt KA, Koprulu M, Kohleick L, Demircan K, Team GHR, Finer S et al.
.
Nanoparticle enriched mass spectrometry proteomics in British South Asians identifies novel variant-protein-disease mechanisms
.
Zanini JC, Pietzner M, Koprulu M, Zoodsma M, Williamson A, Hunt KA, Manolias A, Walter K et al.
.
Proteomic and clinical impact of human knockouts in British South Asians
.
Koprulu M, Wheeler E, Kerrison ND, Denaxas S, Carrasco-Zanini J, Orkin CM, Hemingway H, Wareham NJ et al.
.
Similar and different: systematic investigation of proteogenomic variation between sexes and its relevance for human diseases
.